Response to Comments: Intraosseous Basivertebral Nerve Ablation

This document is a response to stakeholder comments on the proposed Local Coverage Determination for intraosseous basivertebral nerve ablation and explains that the A/B MAC used the best available published clinical evidence to finalize the policy. It cites the CMS Program Integrity Manual (CMS Pub. 100-08) Chapter 13 as the framework for evaluating general acceptance by the medical community. The document does not itself specify clinical coverage indications, limitations, required claim documentation, or frequency limits.

"Final policy and responses are based on available published clinical evidence (peer-reviewed original research, systematic reviews, meta-analyses, evidence-based consensus statements, and clinical ..."

Sign up to see full coverage criteria, indications, and limitations.